#######################
# Document Properties #
#######################
SET DOCUMENT Copyright   = "Copyright © 2019 Fraunhofer Institute SCAI, All rights reserved."
SET DOCUMENT Licenses    = "CC BY 4.0"
SET DOCUMENT ContactInfo = "charles.hoyt@scai.fraunhofer.de"

SET DOCUMENT Name        = "Meldonium improves Huntington's disease mitochondrial dysfunction by restoring peroxisome proliferator-activated receptor γ coactivator 1α expression."
SET DOCUMENT Version     = "1.0.0"
SET DOCUMENT Authors     = ""
SET DOCUMENT Description = "Yojana Gadiya"

##############
# Namespaces #
##############

# Namespaces hosted on https://github.com/pharmacome/terminology
# --------------------------------------------------------------
 DEFINE NAMESPACE CHEBI          AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/chebi-names.belns"
 DEFINE NAMESPACE DRUGBANK       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/drugbank-names.belns"
 DEFINE NAMESPACE DOID           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c0c576e3d3ab9b25a3982251a4ee2fd7c49e1679/external/doid-names.belns"
 DEFINE NAMESPACE ECCODE         AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/ec-code.belns"
 DEFINE NAMESPACE FB             AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/fb-names.belns"
 DEFINE NAMESPACE HBP            AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/export/hbp-names.belns"
 DEFINE NAMESPACE HGNC           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc-names.belns"
 DEFINE NAMESPACE HGNCGENEFAMILY AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc.genefamily-names.belns"
 DEFINE NAMESPACE HP             AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/hp-names.belns"
 DEFINE NAMESPACE GO             AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/go-names.belns"
 DEFINE NAMESPACE INTERPRO       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/interpro-names.belns"
 DEFINE NAMESPACE MESH           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/mesh-names.belns"
 DEFINE NAMESPACE MGI            AS URL "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/mgi-names.belns"
 DEFINE NAMESPACE MIRBASE        AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/mirbase-names.belns"
 DEFINE NAMESPACE NCBIGENE       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/ncbigene.belns"
 DEFINE NAMESPACE PFAM           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/pfam-names.belns"
 DEFINE NAMESPACE RGD            AS URL "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/rgd-names.belns"

# Namespaces hosted on https://github.com/sorgerlab/famplex
# ---------------------------------------------------------
 DEFINE NAMESPACE FPLX           AS URL "https://raw.githubusercontent.com/sorgerlab/famplex/d9ec0526c20795146a9a6aef17496efe1a36cac6/export/famplex.belns"

# Namespaces defined with regular expressions
# -------------------------------------------
 DEFINE NAMESPACE DBSNP          AS PATTERN "rs[0-9]+"
 DEFINE NAMESPACE TAXONOMY       AS PATTERN "^\d+$"
 DEFINE NAMESPACE UNIPROT        AS PATTERN "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\.\d+)?$"
 DEFINE NAMESPACE PUBCHEM        AS PATTERN "^\d+$"

###############
# Annotations #
###############

# Annotations defined with regular expressions
# --------------------------------------------
DEFINE ANNOTATION Species       AS PATTERN "^\d+$"

# Annotations hosted on https://arty.scai.fraunhofer.de/artifactory/bel/annotation
# --------------------------------------------------------------------------------
 DEFINE ANNOTATION Anatomy       AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno"
 DEFINE ANNOTATION CellLine      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno"
 DEFINE ANNOTATION CellStructure AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno"
 DEFINE ANNOTATION Cell          AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno"
 DEFINE ANNOTATION Confidence    AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno"
 DEFINE ANNOTATION Disease       AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno"
 DEFINE ANNOTATION Gender        AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno"
 DEFINE ANNOTATION MeSHAnatomy   AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno"
 DEFINE ANNOTATION MeSHDisease   AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno"
 DEFINE ANNOTATION Subgraph      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno"
 DEFINE ANNOTATION TextLocation  AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"

##############
# Statements #
##############
SET Citation = {"PubMed", "30362565"}

SET Evidence = "Huntington’s disease (HD) is a dominant inherited disorder characterized
by neurodegeneration of cortical and striatal tissue."
SET MeSHAnatomy = {"Neocortex", "Neostriatum"}
path(MESH:"Huntington Disease") -- path(MESH:"Neurodegenerative Diseases")
UNSET MeSHAnatomy

SET Evidence = "Researchers have ascribed the HD pathogenesis to a toxic gain of
mHtt functions, which includes mHTT aggregate formation, transcriptional
dysregulation, defective energy metabolism, and oxidative
stress."
SET MeSHDisease = "Huntington Disease"
p(HGNC:HTT,var("?")) -> a(HBP:"huntingtin aggregates")
p(HGNC:HTT,var("?")) -| path(MESH:"Energy Metabolism")
p(HGNC:HTT,var("?")) -> path(MESH:"Oxidative Stress")
UNSET MeSHDisease

SET Evidence = "It also consists of the loss of wild‐type Htt functions, such as
brain‐derived neurotrophic factor translation, vesicle transport, and
autophagy modulation."
#It : HD pathogenesis
#BDNF : brain‐derived neurotrophic factor
path(MESH:"Huntington Disease") -| act(p(HGNC:HTT))
act(p(HGNC:HTT)) -> p(HGNC:"BDNF")
act(p(HGNC:HTT)) -> path(MESH:"Transport Vesicles")
p(HGNC:HTT) reg path(MESH:"Autophagy")

SET Evidence = "In addition, several converging lines of
research have demonstrated that in different HD models mitochondrial
biogenesis, dynamics, trafficking, and mitophagy are altered,
resulting in a shortage of energy‐generating organelles (Guedes‐Dias
et al., 2016; Guo et al., 2016; Li, Orr, & Li, 2010)."
SET MeSHAnatomy = "Mitochondria"
path(MESH:"Huntington Disease") -| path(MESH:"Organelle Biogenesis")
path(MESH:"Huntington Disease") -> path(MESH:"Autophagy")
UNSET MeSHAnatomy
path(MESH:"Huntington Disease") -| path(MESH:"Mitochondrial Dynamics")
path(MESH:"Huntington Disease") -| path(MESH:"Protein Transport")
path(MESH:"Huntington Disease") -| a(CHEBI:15422)

SET Evidence = "Mitochondrial dysfunction may also originate from
mHtt‐dependent transcriptional dysregulation which results in
abnormal mitochondrial biogenesis and dynamics. Such dysregulation
can also accumulate oxidative damage, inactivating some mitochondrial
metabolic enzymes (Browne et al., 1997; Kumar, Vaish, &
Ratan, 2014)."
SET MeSHAnatomy = "Mitochondria"
p(HGNC:HTT,var("?")) -| path(MESH:"Organelle Biogenesis")
p(HGNC:HTT,var("?")) -| path(MESH:"Mitochondrial Dynamics")
p(HGNC:HTT,var("?")) -| bp(GO:"metabolic process")
UNSET MeSHAnatomy
p(HGNC:HTT,var("?")) -> path(MESH:"Oxidative Stress")

SET Evidence = "Shifts in
fluxes through the different branches of the energy‐generating
pathways could explain the stimulation of fatty acid (FA) oxidation to
compensate for reduced glucose oxidation due to mHtt‐dependent
pyruvate dehydrogenase dysregulation (Cheng, Chang, Wu, & Chen,
2016; Graham et al., 2016; Naia et al., 2017)."
p(HGNC:HTT,var("?")) -| act(p(HGNCGENEFAMILY:"Pyruvate dehydrogenase complex"))
p(HGNCGENEFAMILY:"Pyruvate dehydrogenase complex") -> path(MESH:"Carbohydrate Metabolism")
path(MESH:"Carbohydrate Metabolism") -| path(MESH:"Lipid Metabolism")
p(HGNC:HTT,var("?")) -> path(MESH:"Lipid Metabolism")

SET Evidence = "However, compensatory shifts to generate energy from FAs may
be detrimental to mitochondria since FA overloading might worsen
mitochondrial impairment with an increase of reactive oxygen
species (ROS) production."
#26523 : ROS
path(MESH:"Lipid Metabolism") -> a(HBP:"mitochondrial dysfunction")
a(HBP:"mitochondrial dysfunction") -> a(CHEBI:26523)

SET Evidence = "Meldonium (mildronate; 3‐(2,2,2‐trimethylhydrazinium) propionate;
THP; MET‐88), is known as a cardioprotective drug whose
mechanism of action is based mainly on preserving adenosine
triphosphate production by optimizing energy metabolism during
heart hypoxia (Dambrova, Liepinsh, & Kalvinsh, 2002)."
#131843 : Meldonium
#Cardiotonic Agents : Cardioprotective Agents
a(CHEBI:131843) isA path(MESH:"Cardiotonic Agents")
a(CHEBI:131843) -> a(CHEBI:26523)

SET Evidence = "Meldonium modulates cellular energy metabolism pathways by
lowering intracellular l‐carnitine levels and by reducing the formation of
long‐chain acylcarnitines."
a(CHEBI:131843) reg path(MESH:"Energy Metabolism")

SET Evidence = "These changes redirect the FA metabolism from
mitochondria to peroxisomes, which in turn stimulates short‐ and
medium‐chain FA mitochondrial utilization decreases the production of
cytotoxic intermediate and free radicals from FA β‐oxidation, and
increases glucose metabolism (Dambrova et al., 2016)."
#these changes : caused by Meldonium
#26519 : radicals
SET MeSHAnatomy = "Mitochondria"
a(CHEBI:131843) -| path(MESH:"Lipid Metabolism")
path(MESH:"Lipid Metabolism") -> a(CHEBI:26519)
path(MESH:"Lipid Metabolism") -| path(MESH:"Carbohydrate Metabolism")
UNSET MeSHAnatomy
SET MeSHAnatomy = "Peroxisomes"
a(CHEBI:131843) -> path(MESH:"Lipid Metabolism")
UNSET MeSHAnatomy

SET Evidence = "Researchers
found that meldonium decreases protein expression related to inflammation
and apoptosis in a Parkinson’s disease rat model and an
azidothymidine neurotoxicity model in mice."
SET MeSHDisease = "Parkinson dieseases"
SET Species = "10116"
a(CHEBI:131843) -| path(MESH:"Inflammation")
a(CHEBI:131843) -| path(MESH:"Apoptosis")
UNSET Species
UNSET MeSHDisease
SET MeSHDisease = "Alzheimer Disease"
SET Species = "10090"
a(CHEBI:131843) -> path(MESH:"Neurotoxicity Syndromes")
UNSET Species
UNSTE MeSHDisease

SET Evidence = "They also found that
meldonium has several positive effects in Alzheimer’s disease‐model
mice, including improvement of social recognition and spatial learning and
a reduction of amyloid β peptide load (Beitnere et al., 2014; Isajevs et al.,
2011; Pupure et al., 2008)."
SET MeSHDisease = "Alzheimer Disease"
SET Species = "10090"
a(CHEBI:131843) -> path(MESH:"Recognition (Psychology)")
a(CHEBI:131843) -> path(MESH:"Spatial Learning")
a(CHEBI:131843) -| p(HGNC:APP)
UNSET Species
UNSET MeSHDisease

SET MeSHDisease = "Huntington Disease"

SET Evidence = "In Figure 1c, we demonstrate that Q111/Q111 expression
caused cytotoxicity under serum‐deprived conditions, while STHdhQ7/7
cells were resistant to serum deprivation."
#in serum deprived conditions
#Cell line : STHdh
p(HGNC:HTT,var("Glu")) -> path()


SET Evidence = "The STHdhQ111/Q111 cell viability following
serum deprivation was improved by meldonium (Figure 1d,e)."
#in serum deprivation
#Cell line : STHdh
a(CHEBI:131843) -> path(MESH:"Cell Survival")

SET Evidence  = "Interestingly, western blot analysis demonstrated that 50 μM
meldonium significantly diminished (p < 0.01) the high molecular
weight of mHtt aggregates in the STHdhQ111/111 cell line (Figure 2)."
#in serum deprived conditions
#Cell line : STHdh
a(CHEBI:131843)  -| path(HBP:"huntingtin aggregates")

SET Evidence = "We confirmed that PGC‐1α expression, at both the transcriptional
level (Figure 3a) and translational level (Figure 3b), was
significantly downregulated (p < 0.01) in the STHdhQ111/111 cell line
compared with the STHdhQ7/7 cell line."
#in serum deprived conditions
#Cell line : STHdh
p(HGNC:HTT,var("Glu")) -| r(HGNC:PPARGC1A)
p(HGNC:HTT,var("Glu")) -| p(HGNC:PPARGC1A)

SET Evidence = "Again, meldonium treatment significantly increased the messenger
RNA (mRNA) expression of PGC‐1α in STHdhQ111/111 cells (Figure 3a;
p < 0.01), and the augmented amount of the PGC‐1α protein also
reflected this increment (Figure 3b; p<0.01)."
#in serum deprived conditions
#Cell line : STHdh
a(CHEBI:131843) -> r(HGNC:PPARGC1A)

SET Evidence = "The fluorescent intensity
changes, recorded and analyzed by Cytation 3 Multi‐Mode Reader
(BioTek), demonstrated that meldonium treatment induced a
significant increase in mitochondrial mass levels (Figure 4a)."
#Cell line : STHdh
SET MeSHAnatomy = "Mitochondria"
a(CHEBI:131843) -> path(MESH:"Cell Enlargement")
UNSET MeSHAnatomy

SET Species = "7227"

SET Evidence = "The flies developed age‐dependent neurodegenerative phenotypes,
with initial hyperactivity followed by a progressive loss of coordination
and motor impairment."
#Ataxia : coordination impairment
path(MESH:"Aging") -> path(MESH:"Motor Skills Disorders")
path(MESH:"Aging") -> path(MESH:"Ataxia")

SET Evidence = "Our results clearly indicate that meldonium‐treated Q128HD‐FL
flies had significantly extended lifespans compared with untreated
sibling flies (Figure 5b)."
a(CHEBI:131843) -> path(MESH:"Longevity")

SET Evidence = "Our results show that meldonium treatment significantly improved
the climbing ability of transgenic flies (Figure 5d)."
a(CHEBI:131843) -| path(MESH:"Motor Skills Disorders")
a(CHEBI:131843) -| path(MESH:"Ataxia")

SET Evidence = "Interestingly, we found that the
level of the Spargel transcript decreased with the progression of HD
with a significant decline in the late symptomatic Q128HD‐FL
(Figure 5e)."
#Q128HD-FL : D.melanogaster model for HD
p(HGNC:HTT,var("Glu")) -| r(HGNC:PPARGC1A)

SET Evidence = "We next performed this assay in meldonium‐treated siblings, and
our results clearly indicate that in HD flies fed with meldonium,
Spargel is significantly upregulated (about 1.6–1.8‐fold) in all time
points tested (Figure 5f)."
#Q128HD-Fl
composite(p(HGNC:HTT,var("Glu")), a(CHEBI:131843)) -> r(HGNC:PPARGC1A)

SET Evidence = "In conclusion, the dPGC‐1α/Spargel gene in D. melanogaster was
significantly upregulated in the head tissues of the HD flies after
meldonium treatment, starting from the early stage of HD"
#Q128HD-Fl
SET MeSHAnatomy = "Brain"
a(CHEBI:131843) -> r(HGNC:PPARGC1A)
UNSET MeSHAnatomy

SET Evidence = "Our results clearly demonstrate that HD transgenic flies
have an increased level of ROS when compared with wild‐type flies
(Figure 6), confirming the data obtained in other HD models (Scialò
et al., 2016)"
#26523 : ROS
p(HGNC:HTT,var("Glu")) -> a(CHEBI:26523)

SET Evidence = "In HD transgenic flies, meldonium supplementation
reduced the level of oxidative stress in brain tissues (Figure 6)."
SET MeSHAnatomy = "Brain"
composite(p(HGNC:HTT,var("Glu")), a(CHEBI:131843)) -| a(CHEBI:26523)
UNSET MeSHAnatomy

UNSET Species
UNSET MeSHDisease
